Vendor, Morrisville, NC
TG Therapeutics Inc.
UEI JKPZKD19WMD7, CAGE 8TBE4
2 awards and $0 obligated between January 5, 2024 and September 2, 2026, 100% under full and open competition, against 501.5 offers on average where reported. 6 of the awards trace back to a SAM.gov solicitation on this site.
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 2 |
Solicitations it won
SAM.gov opportunities whose award USAspending attributes to this vendor.
- Anti CD20 Antibodies
Department of Veterans Affairs, Nac Pharmaceuticals
Award noticeNAICS 32541236E79724R0006Awarded to TG Therapeutics Inc. for $186,776,520
Posted Apr 17, 20246 publications
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 36E79724D0024April 17, 2024, Full and Open Competition, 4 offersSolicitation | Nac PharmaceuticalsDepartment of Veterans Affairs | New Award for Ublituximab-Xiiy 150mg/6ml Injection (Anti-Cd20 Antibodies with TG Therapeutics. Period of Performance June 17, 2024 - June 16NAICS 325412, PSC 6505 | $0 |
| 36F79723D0120January 5, 2024, Full and Open Competition, 999 offers | Nac Federal Supply ScheduleDepartment of Veterans Affairs | 65IB Administrative Correction: Maximum OrderNAICS 325412, PSC 6505 | $0 |
- Product and service codes
- 6505 Drugs and Biologicals
- Transactions
- 12 across 2 awards